Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-69.34	20.15	65.73
Graham Fair Price	42.30	0.53	0.37
PEG	-54.82	0.35	-0.77
Price/Book	2.32	2.47	2.41
Price/Cash Flow	87.45	-12.67	-100.98
Prices/Earnings	-48.84	35.47	69.33
Price/Sales	-44.69	2.05	3.70
Price/FCF	87.45	-12.67	-100.98
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-4.73	0.16	0.16
Operating Margin	-25.13	0.05	0.06
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	0.02	100.00
ROIC	< 0.005	< 0.005	40.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.04	11.12	-99.67
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.57	0.38	-32.48
EPS QOQ	-0.90	1.01	13.25
FCF QOQ	-3.03	-7.15	-136.45
Revenue QOQ	-0.51	0.85	65.90
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	13.00	6.96	-46.44
Days Sales Outstanding (DSO)	114.25	76.47	-33.07
Inventory Turnover	6.92	12.93	86.70
Debt/Capitalization	0.47	0.47	-1.32
Quick Ratio	1.22	1.43	17.20
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.84	0.85	0.62
Cash	0.27	0.27	0.62
Capex	< 0.005	-0.14	-1788.19
Free Cash Flow	-0.02	-0.16	-720.52
Revenue	0.55	1.02	86.14
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.53	1.53	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.79	4.02	-68.55
Naive Interpretation	Member

06 - Financial Health · Weak

Rating